000877230 001__ 877230
000877230 005__ 20210130004936.0
000877230 0247_ $$2doi$$a10.3390/toxins12050337
000877230 0247_ $$2Handle$$a2128/25729
000877230 0247_ $$2pmid$$apmid:32443933
000877230 0247_ $$2WOS$$aWOS:000541799400017
000877230 037__ $$aFZJ-2020-02057
000877230 082__ $$a610
000877230 1001_ $$0P:(DE-Juel1)174331$$aPietschmann, Jan$$b0
000877230 245__ $$aSensitive Aflatoxin B1 Detection Using Nanoparticle-Based Competitive Magnetic Immunodetection
000877230 260__ $$aBasel$$bMDPI$$c2020
000877230 3367_ $$2DRIVER$$aarticle
000877230 3367_ $$2DataCite$$aOutput Types/Journal article
000877230 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1600885678_17520
000877230 3367_ $$2BibTeX$$aARTICLE
000877230 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000877230 3367_ $$00$$2EndNote$$aJournal Article
000877230 520__ $$aFood and crop contaminations with mycotoxins are a severe health risk for consumers and cause high economic losses worldwide. Currently, different chromatographic- and immunobased methods are used to detect mycotoxins within different sample matrices. There is a need for novel, highly sensitive detection technologies that avoid time-consuming procedures and expensive laboratory equipment but still provide sufficient sensitivity to achieve the mandated detection limit for mycotoxin content. Here we describe a novel, highly sensitive, and portable aflatoxin B1 detection approach using competitive magnetic immunodetection (cMID). As a reference method, a competitive ELISA optimized by checkerboard titration was established. For the novel cMID procedure, immunofiltration columns, coated with aflatoxin B1-BSA conjugate were used for competitive enrichment of biotinylated aflatoxin B1-specific antibodies. Subsequently, magnetic particles functionalized with streptavidin can be applied to magnetically label retained antibodies. By means of frequency mixing technology, particles were detected and quantified corresponding to the aflatoxin content in the sample. After the optimization of assay conditions, we successfully demonstrated the new competitive magnetic detection approach with a comparable detection limit of 1.1 ng aflatoxin B1 per ml sample to the cELISA reference method. Our results indicate that thecMID is a promising method reducing the risks of processing contaminated commodities.
000877230 536__ $$0G:(DE-HGF)POF3-523$$a523 - Controlling Configuration-Based Phenomena (POF3-523)$$cPOF3-523$$fPOF III$$x0
000877230 588__ $$aDataset connected to CrossRef
000877230 7001_ $$0P:(DE-HGF)0$$aSpiegel, Holger$$b1
000877230 7001_ $$0P:(DE-Juel1)128697$$aKrause, Hans-Joachim$$b2
000877230 7001_ $$0P:(DE-HGF)0$$aSchillberg, Stefan$$b3
000877230 7001_ $$0P:(DE-HGF)0$$aSchröper, Florian$$b4$$eCorresponding author
000877230 773__ $$0PERI:(DE-600)2518395-3$$a10.3390/toxins12050337$$gVol. 12, no. 5, p. 337 -$$n5$$p337 -$$tToxins$$v12$$x2072-6651$$y2020
000877230 8564_ $$uhttps://juser.fz-juelich.de/record/877230/files/toxins-12-00337.pdf$$yOpenAccess
000877230 909CO $$ooai:juser.fz-juelich.de:877230$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000877230 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)174331$$aForschungszentrum Jülich$$b0$$kFZJ
000877230 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)128697$$aForschungszentrum Jülich$$b2$$kFZJ
000877230 9131_ $$0G:(DE-HGF)POF3-523$$1G:(DE-HGF)POF3-520$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lFuture Information Technology - Fundamentals, Novel Concepts and Energy Efficiency (FIT)$$vControlling Configuration-Based Phenomena$$x0
000877230 9141_ $$y2020
000877230 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000877230 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2019-12-21
000877230 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2019-12-21
000877230 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2019-12-21
000877230 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2019-12-21
000877230 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2019-12-21
000877230 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bTOXINS : 2018$$d2019-12-21
000877230 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2019-12-21
000877230 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2019-12-21
000877230 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2019-12-21
000877230 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2019-12-21
000877230 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2019-12-21
000877230 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2019-12-21
000877230 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000877230 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2019-12-21
000877230 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$f2019-12-21
000877230 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database$$d2019-12-21
000877230 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2019-12-21
000877230 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2019-12-21
000877230 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2019-12-21
000877230 920__ $$lyes
000877230 9201_ $$0I:(DE-Juel1)IBI-3-20200312$$kIBI-3$$lBioelektronik$$x0
000877230 980__ $$ajournal
000877230 980__ $$aVDB
000877230 980__ $$aUNRESTRICTED
000877230 980__ $$aI:(DE-Juel1)IBI-3-20200312
000877230 9801_ $$aFullTexts